Pfizer to buy Biohaven for $11.6 billion By / On May 13, 2022 / At 12:52 am / In Chemical world 70 Views Deal centers on a potential blockbuster drug for migraine Post navigation Prev PostAutomated research workflows need more investment, report says Next PostThe US is beefing up its battery materials supply chain You May Also Like Learning how plants make limonoids On January 30, 2023 | In Chemical world AI model accurately classifies reaction mechanisms On January 30, 2023 | In Chemical world How to make effective scientific posters On January 30, 2023 | In Chemical world
By